Assessing the activity of perianal Crohn's disease: Comparison of clinical indices and computer-assisted anal ultrasound

Inflammatory Bowel Diseases

Volumn 15, Issue 5, 2009, Pages 742-749

  Losco, Alessandra ^a   Vigano, Chiara ^a   Conte, Dario ^a,b   Cesana, Bruno Mario ^c   Basilisco, Guido ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Disease activity measurements; Fistulae in Crohn's disease; Imaging

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; METRONIDAZOLE;

ADULT; AGED; ANALYTIC METHOD; ANTIBIOTIC THERAPY; ANUS FISTULA; ANUS SURGERY; ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED RADIOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; FEMALE; FISTULA DRAINAGE ASSESSMENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIANAL ABSCESS; PERIANAL DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SKIN INDURATION; SURGICAL DRAINAGE;

ADULT; AGED; ANUS DISEASES; CROHN DISEASE; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RECTAL FISTULA; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 67650340196     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20826     Document Type: Article

References (34)

1. Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn's disease. Gut. 1995;37:696-701.
2. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876-885.
3. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862-869.
4. Rutgeerts P. Treatment of perianal fistulizing Crohn's disease. Aliment Pharmacol Ther. 2004;20:106-110.
5. Schwartz DA, White CM, Wise PE, et al. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Inflamm Bowel Dis. 2005;11:727-732.
6. Ardizzone S, Maconi G, Colombo E, et al. Perianal fistulae following infliximab treatment. Inflamm Bowel Dis. 2004;10:91-96.
7. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 1980;302:981-987.
8. Alexander-Williams J, Hellers G, Hughes LE, et al. Classification of perianal Crohn's disease. Gastroenterol Int. 1992;5:216-220.
9. Allan A, Linares L, Spooner HA, et al. Clinical index to quantitate symptoms of perianal Crohn's disease. Dis Colon Rectum. 1992;35: 656-661.
10. Pikarsky AJ, Gervaz P, Wexner SD. Perianal Crohn disease. A new scoring system to evaluate and predict outcome of surgical intervention. Arch Surg. 2002;137:774-777.
11. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398-1405.
12. Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol. 2003;98:332-339.
13. Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther. 2003;18: 1003-1008.
14. Bell SJ, Halligan S, Windsor ACJ, et al. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2003;17:387-393.
15. Topstad DR, Panaccione R, Heine JA, et al. Combined seton placement, infliximab, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease. Dis Colon Rectum. 2003;46: 577-583.
16. Dejaco C, Harrer M, Waldhoer T, et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther. 2003;18:1113-1120.
17. Schroder O, Blumenstein I, Schulte-Bockholt A, et al. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine. Aliment Pharmacol Ther. 2004;19:295-301.
18. Gonzalez-lama Y, Abreu L, Vera MI, et al. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease. Inflamm Bowel Dis. 2005;11:8-15.
19. Talbot C, Sagar SM, Johnston MJ, et al. Infliximab in the surgical management of complex fistulating anal Crohn's disease. Colorectal Dis. 2005;7:164-168.
20. West RL, van der Woude CJ, Hansen BE, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2004;20:1329-1336.
21. Hyder SA, Travis SPL, Jewell DP, et al. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006;49:1-5.
22. Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. J Clin Gastroenterol. 1995;20:27-32.
23. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indexes and efficacy end-points for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122:512-530.
24. Schwartz DA, Herdman CR. The medical treatment of Crohn's perianal fistulas. Aliment Pharmacol Ther. 2004;19:953-967.
25. Caprioli F, Losco A, Viganò C, et al. Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease. Am J Gastroenterol. 2006; 101:1551-1558.
26. Sands BE. Crohn's disease. In: Feldman M, Friedman LS, Sleisenger MH, eds. Gastrointestinal and Liver Disease, 7th ed. Philadelphia: Saunders; 2002;2:2005-2038.
27. Kundel HL, Polansky M. Measurement of observer agreement. Radiology. 2003;228:303-308.
28. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis. 1986;1:104-107.
29. van Bodegraven AA, Sloots CEJ, Felt-Bersina RJF, et al. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2002;45:39-46.
30. Schwerk WB, Durr HK. Ultrasound gray-scale pattern and guided aspiration puncture of abdominal abscesses. J Clin Ultrasound. 1981;9: 389-396.
31. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
32. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterology. 2003;125:1508-1530.
33. Buchanan GN, Halligan S, Bartram CI, et al. Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology. 2004;233:674-681.
34. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology. 2001;121:1064-1072.